Similar companies
Tvardi Therapeutics X Follower Count
Tvardi Therapeutics has 130 followers on X (formerly Twitter), up 4.0% over the past three months. Rising follower counts on X point to growing public interest and brand visibility.
With 130 followers, Tvardi Therapeutics has a smaller X following than industry peers like Amgen (118,787) and Gilead Sciences (72,341).
How Tvardi Therapeutics’s X Growth Feeds the TVRD AI Score
X follower trends are particularly relevant for companies with strong direct-to-consumer brands or high-profile leadership. A follower count is not a stock price on its own, but for consumer-facing companies a sustained shift in following can reflect changing brand momentum. AltIndex feeds Tvardi Therapeutics’s X following into the TVRD AI Score as one of 25+ alternative data signals, weighed against hiring, web traffic, sentiment, and fundamentals.
For Tvardi Therapeutics’s reach on other platforms, see Tvardi Therapeutics Instagram followers, TikTok followers, YouTube subscribers, and Facebook followers.
For real-time conversation volume, see TVRD X mentions. For other demand signals, see web traffic, app downloads, and Google Trends.
Month over Month
| Jul 2026 | 130 | |
| Jun 2026 | 125 | |
| May 2026 | 126 |
Tvardi Therapeutics X (Twitter) Followers: Frequently Asked Questions
Tvardi Therapeutics has 130 followers (130) on X (formerly Twitter), based on AltIndex’s tracking of the company’s official X account.
Tvardi Therapeutics's X following is growing, up 4.0% over the past three months. View the trend chart above for the full history.
X follower trends are most telling for companies with strong direct-to-consumer brands or high-profile leadership. No single data point predicts a stock on its own, but a sustained change in Tvardi Therapeutics's following can reflect shifting public interest. That is why AltIndex combines Tvardi Therapeutics's X following with web traffic, hiring, sentiment, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Tvardi Therapeutics underperforms its industry peers when it comes to X Followers, ranking dead last.
With fewer than 1,000 followers, Tvardi Therapeutics' X account is in its growth phase, focusing on building its audience. This suggests a niche but potentially dedicated following, important for targeted engagement.
Sign up and get more insights on Tvardi Therapeutics.
See Tvardi Therapeutics’s complete x followers history
Sign up to unlock 1-year and all-time charts for TVRD — plus 25+ alternative data signals, AI Scores, and real-time alerts.
Sign up
